EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
Status:
Terminated
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of EMD 121974 in treating patients who have
HIV-related Kaposi's sarcoma. EMD 121974 may stop the growth of Kaposi's sarcoma by stopping
blood flow to the tumor.